Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Hematology journal rankings 2024
83 ranked journals · Subfield in Medicine
Hematology has 83 ranked journals in 2024. The median journal has an OJR of 0.59, below the world average of 1.00, down 0.04 on 2023; Q1 starts at OJR 1.06. The top three are The Lancet Haematology, Leukemia, and Blood Cancer Journal.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Hematology83
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
83 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1The Lancet HaematologyElsevier BV · Netherlands | 3.39Q1 | 9.88 1.27 up from 2023 | 408 | 29% | $7,280 | ||
2LeukemiaSpringer Nature · United Kingdom | 3.08Q1 | 10.17 0.15 down from 2023 | 917 | 75% | $5,190 | ||
3Blood Cancer JournalOASpringer Nature · United Kingdom | 3.02Q1 | 7.23 1.38 down from 2023 | 541 | 100% | $5,290 | ||
4BloodElsevier BV · United States | 2.75Q1 | 8.73 0.26 down from 2023 | 2,232 | 57% | $5,500 | ||
5Blood Cancer DiscoveryAmerican Association for Cancer Research · United States | 2.53Q1 | 7.05 1.26 down from 2023 | 137 | 37% | — | ||
6Blood ReviewsElsevier BV · United Kingdom | 2.24Q1 | 6.08 0.38 down from 2023 | 195 | 60% | $5,220 | ||
7Blood AdvancesOAElsevier BV · United States | 2.04Q1 | 5.78 0.70 down from 2023 | 2,093 | 100% | $3,800 | ||
8American Journal of HematologyWiley · United States | 1.85Q1 | 5.56 0.17 up from 2023 | 1,007 | 90% | $5,450 | ||
9Seminars in HematologyElsevier BV · United States | 1.66Q1 | 4.32 1.58 down from 2023 | 95 | 49% | $4,070 | ||
10Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 1.61Q1 | 4.18 0.97 down from 2023 | 1,103 | 99% | $3,750 | ||
11HematologyAmerican Society of Hematology · United States | 1.49Q1 | 3.84 0.01 down from 2023 | 289 | 100% | — | ||
12AnemiaOAHindawi Publishing Corporation · United Kingdom | 1.39Q1 | 3.41 0.08 up from 2023 | 31 | 100% | $1,100 | ||
13Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.36Q1 | 4.43 0.77 up from 2023 | 961 | 100% | $3,650 | ||
14HaematologicaOAFerrata Storti Foundation · Italy | 1.31Q1 | 3.65 0.17 down from 2023 | 1,157 | 100% | $2,157 | ||
15HemaSphereOAWolters Kluwer · United States | 1.28Q1 | 3.77 0.33 up from 2023 | 437 | 100% | $2,480 | ||
16Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.24Q1 | 3.81 0.32 up from 2023 | 118 | 42% | $3,790 | ||
17Therapeutic Advances in HematologyOASAGE Publishing · United Kingdom | 1.23Q1 | 3.65 0.03 up from 2023 | 172 | 100% | $2,650 | ||
18Journal of Blood MedicineOADove Medical Press · New Zealand | 1.18Q1 | 3.52 0.79 up from 2023 | 246 | 100% | $2,320 | ||
19Pediatric RheumatologyOABioMed Central · United Kingdom | 1.11Q1 | 2.63 0.70 down from 2023 | 418 | 100% | $3,090 | ||
20Research and Practice in Thrombosis and HaemostasisOAElsevier BV · United States | 1.08Q1 | 2.88 0.13 down from 2023 | 696 | 100% | $2,250 | ||
21Bone Marrow TransplantationSpringer Nature · United Kingdom | 1.06Q1 | 3.10 0.04 up from 2023 | 888 | 53% | $4,990 | ||
22British Journal of HaematologyWiley · United Kingdom | 0.97Q2 | 2.66 0.71 down from 2023 | 1,743 | 70% | $5,190 | ||
23Current Opinion in HematologyLippincott Williams & Wilkins · United States | 0.97Q2 | 2.90 0.35 down from 2023 | 126 | 45% | — | ||
24PlateletsOAInforma · United Kingdom | 0.93Q2 | 2.64 0.19 down from 2023 | 286 | 100% | $2,970 | ||
25Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 0.89Q2 | 2.40 0.08 down from 2023 | 143 | 51% | $3,730 | ||
26Transfusion Medicine ReviewsElsevier BV · United States | 0.88Q2 | 2.51 0.21 down from 2023 | 92 | 48% | $3,970 | ||
27European Journal Of HaematologyWiley · United Kingdom | 0.85Q2 | 2.41 0.08 up from 2023 | 542 | 76% | $4,650 | ||
28Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 0.82Q2 | 3.57 0.19 down from 2023 | 371 | 44% | — | ||
29Journal of Clinical ApheresisWiley · United States | 0.82Q2 | 2.87 1.36 up from 2023 | 210 | 65% | $3,920 | ||
30Annals of Laboratory MedicineOASeoul National University · South Korea | 0.80Q2 | 2.43 0.21 down from 2023 | 285 | 100% | — | ||
31Expert Review of HematologyTaylor & Francis · United Kingdom | 0.78Q2 | 2.38 0.21 down from 2023 | 298 | 34% | — | ||
32Current Research in Translational MedicineElsevier BV · France | 0.76Q2 | 2.11 0.82 down from 2023 | 120 | 30% | $3,700 | ||
33HaemophiliaWiley · United Kingdom | 0.74Q2 | 2.42 0.03 down from 2023 | 633 | 73% | $4,760 | ||
34Clinical Hematology InternationalOASpringer Nature · Netherlands | 0.71Q2 | 1.90 0.56 down from 2023 | 71 | 100% | — | ||
35Annals of HematologyOASpringer Science+Business Media · Germany | 0.71Q2 | 2.01 0.32 down from 2023 | 1,179 | 38% | $4,590 | ||
36Blood ResearchOASouth Korea | 0.70Q2 | 2.35 0.32 up from 2023 | 208 | 100% | $2,290 | ||
37Experimental HematologyElsevier BV · United States | 0.69Q2 | 2.04 0.48 down from 2023 | 225 | 100% | $3,250 | ||
38Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 0.69Q2 | 2.05 0.09 up from 2023 | 163 | 100% | $1,670 | ||
39HämostaseologieThieme Medical Publishers (Germany) · Germany | 0.65Q2 | 1.34 1.45 down from 2023 | 205 | 32% | — | ||
40International Journal of HematologySpringer Science+Business Media · Japan | 0.64Q2 | 2.01 0.10 up from 2023 | 607 | 37% | $4,390 | ||
41HematologyOAManey Publishing · United Kingdom | 0.60Q2 | 1.70 0.48 down from 2023 | 484 | 100% | $2,557 | ||
42Leukemia ResearchElsevier BV · United Kingdom | 0.59Q2 | 1.81 0.03 down from 2023 | 409 | 33% | $3,910 | ||
43TransfusionWiley · United States | 0.57Q3 | 1.80 0.33 down from 2023 | 1,148 | 67% | $4,100 | ||
44Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.57Q3 | 1.74 0.07 down from 2023 | 732 | 6% | $3,890 | ||
45Acta HaematologicaKarger Publishers · Switzerland | 0.57Q3 | 1.55 0.57 down from 2023 | 177 | 42% | — | ||
46Blood ScienceOAWolters Kluwer · United States | 0.55Q3 | 2.29 1.09 up from 2023 | 106 | 100% | — | ||
47Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.54Q3 | 1.59 0.09 down from 2023 | 1,114 | 30% | — | ||
48Hematology ReportsOAPAGEPress (Italy) | 0.52Q3 | 1.57 0.38 up from 2023 | 148 | 100% | $1,930 | ||
49Cytometry Part B Clinical CytometryWiley · United States | 0.51Q3 | 2.08 0.27 up from 2023 | 140 | 80% | $3,800 | ||
50Journal of HematologyElmer Press Inc. · Canada | 0.50Q3 | 1.53 0.11 down from 2023 | 112 | 100% | — |
Subfields of Medicine, with Hematology highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
11 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 83
- Window papers (baseline)
- 47,502 +10.4% from indicator year 2021
- Median OJR
- 0.587 -13.9% from indicator year 2021
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.